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Abstract
Nowadays, the submission of a research project to an ethical committee and 
its approval is mandatory. However, researchers often overlook this obligation, 
because they are too engaged in the design and the process of construction of 
the study, because of the common tight deadlines, and many times because some 
devaluation of the role of the committee. Based on our experience of 10 years 
working in an ethical committee, we propose a way to get close researchers and 
evaluators, respecting their own aims but bringing them together as partners in 
the investigation process, protecting patients’ values, at the same time that makes 
it possible to implement strategies to answer to the research question and to create 
useful knowledge. Our aim is to smoothen the way researchers look to the ethical 
committee and, at the same time, to make them understand what really is at stake. 
Ethics should be a commitment for all and not an obligation.
Keywords: ethics, ethics committees, research, ethical analysis, beneficence, 
personal autonomy
1. Introduction
Medicine is born from the human need to survive to diseases. At first, someone 
within the tribe began to realize the constellation of symptoms and signs that 
defined the diagnosis, for which a proper treatment could make the difference in the 
course of the disease. The so-defined medical act gave him the mastery over life and 
death. The awareness of this power has given rise to a set of self-regulating norms, 
early transmitted to the disciples who applied to learn the noble art of healing. This 
ethical code became known as the Hippocratic oath of the School of Kos, in honor 
to Hippocrates, the father of scientific medicine, known for having received himself 
the knowledge from the hands of Asclepius the Greek god of medicine [1].
Based on a solid knowledge derived from the scientific method, medicine commits 
itself to the patient and society in simple but basic principles of beneficence, non-
maleficence, justice, truth, confidentiality, and respect for the human being. This 
commitment should be enough to ensure unblemished medical practice, both in the 
care and, no less important, in the research and experimentation.
But the twentieth century and the horrors exposed by the Holocaust of the 
Second Great War came to demonstrate that it was not enough.
On August 8, 1945, the countries that formed the Allied Forces in World War 
II signed the constitution agreement of the International Military Tribunal, to 
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prosecute the Nazi officers on charges of committing peace crimes, war crimes, 
and crimes against humanity (Control Council Law No. 10: Punishment of 
persons guilty of war crimes, crimes against peace and humanity). The initial trial 
in the city of Nuremberg, Germany, was followed by 12 other trials until 1949. The 
first of these trials became known as the medical case and resulted in the convic-
tion of 16 of the 23 defendants for their involvement, among others, in research 
projects (high-altitude experiments; freezing experiments; malaria experiments; 
mustard gas experiments; sulfanilamide experiments; bone, muscle, and nerve 
regeneration experiments; bone transplantation experiments; seawater experi-
ments; epidemic hepatitis experiments; sterilization experiments; vaccination 
experiments for yellow fever, smallpox, typhus and other rickettsiosis, paraty-
phoid A and B, cholera, and diphtheria; poison experiments; and incendiary 
bomb experiments) [2].
The question wasn’t the possibility of conducting research in human beings but 
the way and circumstances under which it was done. This court had to define what 
were the permissible medical experiments, in accordance with ethics, morals, and 
law. The 10 principles emanating from this court formed the first code of ethical 
appreciation for research involving humans [2], later developed and extended in 
its application by the World Medical Association’s Declaration of Helsinki (1964) 
[3]. Nevertheless, ethical evaluation was still a commitment of the investigators. 
The case of Tuskegee, USA, syphilis experience (1932–1972) has warned of the 
need for direct follow-up and the establishment of independent committees able to 
ensure the appraisal, evaluation, and guidance of research protocols, as proposed 
by the following Belmont Report [4]. The increasing complexity of ethical problems 
with the advance of knowledge has dictated the structuring of responses at the 
national level. In 1983, in France, President François Mitterrand established the 
“Consultatif National d’Ethique Committee,” the first ethics committee for health 
and life sciences, with the mission to opine on ethical and social problems arising 
from progress in the fields of biology, medicine, and health. The increased specific-
ity of experimental research in the new treatments has led to the establishment 
of research ethics committees with the highest technical capacity to fulfill their 
mission (US Institutional Review Boards, and the Ethics Committees for Clinical 
Research in Europe).
2. The ethical principle
The ethics committees are now multidisciplinary boards, including medicine, 
nursing, social work, law, pastoral care, healthcare administration, and various spe-
cialty areas. Their role includes the ethics education, policy formation and review, 
ethics consultation, and research ethics [5]. In clinical investigation, every protocol 
must be submitted previously to the beginning of the study for consideration, com-
ment, guidance, and approval. The ethics committees must be independent of the 
researcher, the promoter, and the sponsor and transparent in their function [6].
The ethics committees for health, especially in the context of clinical research, 
are thus born not from an internalization of the need for self-regulation but from 
an external, regulatory, and legal imposition. Since the beginning, they assume a 
problem-solving police nature that they rarely escape, as their mission includes the 
laws and regulations as well as applicable international norms and standards. It is 
common that the ethics committees focus much attention on legal and procedural 
aspects, answering to this feature, more than applying an individualistic appraisal 
of the factual project. Consequently, the researchers look at them more as obstacles 
to the execution of projects than as partners in their implementation.
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Ethic must be above the law, respecting it, but discussing it and framing it 
towards the specific case [7], keeping in mind the protection of the human being. 
The primacy of ethics, which compromises us all, is certainly not the primacy of 
the ethics committees, as if they were the exclusive holders of the absolute truth, or 
its juridical version. The ethical appraisals must return to the Hippocratic matrix 
of the basic ethical principles to find their guiding path, combining the need for 
innovation and development in health, through research strategies, with respect for 
the human being in his or her dignity and vulnerability, in health or in illness, in the 
daily care they need, or in participating in a research project.
The ethical principles were defined in 1971 by Thomas Beauchamp and James 
Childress [8]. Beneficence, non-maleficence, justice, and autonomy had become the 
basis of bioethical decision-making in the last 50 years. Despite the heated discussion 
about their interpretation, importance, and role of each one, they remain the most 
internationally accepted. Nevertheless, there’s some controversy about their inability to 
answer to all the challenges posed by the complexity of current biomedical decisions.
The same principles were adopted by clinical research as a key for ethical evalu-
ation, ensuring the protection of the rights of participants. But there are several 
differences in their application.
Beneficence refers to the promotion of the best practices to improve the patient. 
However, many times, the beneficiary of the results in a research project is not the 
participant but the all other population that will receive the medicine under tests [9]. 
The principle of non-maleficence derives from the Hippocratic sentence of “primum 
non nocere,” which means that doctor abstains from practice that put patients under 
danger. Although we may argue that the risk of harm is under control, we cannot 
guarantee for certain even in observational research. The principle of justice and 
equity reminds us to provide the best treatments to those who really need them. The 
randomization of the sample removes any selective allocation criteria. The autonomy 
respects the patient’s freedom of choice, based on a sufficient given information. The 
informed consent freely expressed gives legitimacy to the inclusion of participants. 
Although the guaranties of the possibility of self-exclusion, no one really wants that 
to happen, which may compromise the very principle. The definition of autonomy 
has evolved over the last years, as the boundaries for information and self-determi-
nation, leading to structured forms almost widely accepted, but depersonalized and 
eventually far from the participant.
Over time, other ethical principles have been defined and applied in scientific 
research. As ethical principles, by definition, require action, new procedures have 
been adopted to ensure respect for the participants in investigation protocols.
In 1978, the Belmont Report of the National Commission for the Protection of 
Human Subjects of Biomedical and Behavioral Research [4] described the ethical 
principles for research in human beings: beneficence, justice, and the respect for 
the person. The respect for the participant implies that researcher must recog-
nize the subjects’ autonomy to their own will and assume the duty to protect the 
most vulnerable.
In the 1998 Barcelona Declaration, a panel of experts defined the principles of 
autonomy, dignity, integrity, and vulnerability [10]. Autonomy comes up as an ideal 
to reach. Dignity is an intrinsic value of the individual, meeting himself with others. 
Integrity is the right to inviolability, implying the respect for privacy, personal 
ideas and expectations, and for patient’s understanding of his own life and illness. 
Vulnerability expresses the susceptibility to be hurt. It is commonly understood as 
the condition of a patient before the threat of disease. In investigation, vulnerability 
refers to the fragility of participants before the methods. It implies the duty of not 
to harm the integrity of the participants and, at the same time, to protect their 
integrity. Classically, we consider children, pregnant women, and elders, but there 
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are many other ways of turning vulnerable, such as the invitation to participate in a 
research of the doctor to his patient.
More than the statement in the ethical issues of a paper, assuring that the 
authors were committed with Declaration of Helsinki and Oviedo Convention for 
the protection of human rights and dignity of the human being with regard to the 
application of biology and medicine, researchers should incorporate the ethical 
principles since the formulation of the research question and in the entire defini-
tion of study design and results analysis, in the assumptions they make, and in the 
decisions they take.
3. Checklist of the ethical appraisal
The ethical appraisal of a research protocol often starts with a descriptive char-
acterization of the study. Checking the presence or absence of certain elements in 
the protocol may assist this task. Table 1 presents the checklist of ethical appraisal. 
It does not pretend to be a definitive tool of decision, since the ethical appraisal of a 
research protocol is not an assignment that may be reduced to a checklist. This table 
should be perceived as a summary tool to help structure and guide critical thinking 
regarding ethical research assessment.
Overall the research protocol proposal is assessed for its merit and integrity 
alongside with the description of appropriate and rigorous methods and procedures 
committed to non-maleficence. The use of sound scientific methods is warranted. 
Although this is not the main focus of the consideration it is important to assure 
that the use of resources and enrolment of participants is based on solid scien-
tific grounds. Additionally, appropriate academic conduct in terms of references 
Ethical appraisal
Research team Yes No Merit and integrity
Individual researchers curriculum 
vitae
• Research team CVs are expected 
to demonstrate capacity to 
develop the study
• Relevance and feasibility of the 
study is expected
Problem Yes No
Coherent rationale supported by 
literature
Questions Yes No
Clear and answerable research 
questions
Design Yes No Appropriate and rigorous
Experimental • Coherence between research 
questions and research design is 
expected
• Efficient resource allocation is 
expected
• Appropriate bias identification 
and mitigation strategies are 
expected
Pre-post intervention
Control group
Observational
Cohort
Case–control
Cross-sectional
Qualitative
Validation (e.g., scale development)
Mixed methodology
Other
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and authorship authorizations in the use of tools and instruments for research is 
required. The main focus of attention is usually placed in all the interactions with 
participants. From first contact where the study is presented to enrollment in the 
study followed by all the activities required to the end of the study and eventual 
subsequent follow-up.
Ethical appraisal
Participants enrolment Yes No Non-maleficence
Clear description of the procedure to 
enroll participants
• Consideration of benefits and 
costs (risks) weighting for 
individual and for community 
interests is expected
• Commitment to respect the 
integrity, dignity and autonomy 
of participants is expected
• Appropriate informed consent 
presentation is expected
• Appropriate procedure of data 
protection is expected
• Appropriate procedure for 
adverse event reporting is 
expected
Data collection Yes No
Gathering data from people
Questionnaire
Individual interview
Group interview (e.g., focus group)
Biological sampling (blood, urine, 
saliva, sputum, feces, semen, tissue or 
other bodily fluids)
Gathering data from clinical records
Anonymized or pseudonymized data
Written informed consent from 
participants
Data storage Yes No
Safety measures for database 
management
Participant safety Yes No
Written informed consent from 
participants
Procedure for reporting of adverse 
events
Identification of possible risks or 
harm to participants (e.g., stress or 
anxiety)
Insurance (intervention studies, if 
applicable)
Data analysis Yes No Merit and integrity
Exploratory • Detailed explanation of statisti-
cal analytical plan is expected 
(viz., identifying all variables 
and statistical tests use)
• Commitment to report and 
make results public is expected
• Declaration of any conflict of 
interest is expected
Prespecified
Reporting Yes No
Publication or registry of the 
protocol
Compromise to send a report of the 
research
Intention to publish the study
Funding Yes No
Funding protocol (if applicable)
Table 1. 
Checklist of the ethical appraisal.
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4. Common mistakes
The ethics committee of the Northern Regional Health Administration of 
Portuguese Health Minister was created in 2009 as the first ethical committee in 
primary care in Portugal. The Northern Regional Health Administration covers a 
population of about 3.5 million people and have about 9000 collaborators (2776 
physicians and 2829 nurses). We have a large experience, counting over 1200 
processes evaluated till the end of 2018 (95% research projects in primary care 
settings). Also we contributed to ethical education among providers implementing 
several courses on ethical topics, particularly focusing ethics in research.
During this period the discussion on ethical issues increased considerably 
among physicians and researchers, accompanying Portuguese legislative changes 
in ethical committees and access and protection of personal data. Ethics does not 
belong to any one in special: it is a commitment of all. Nevertheless, belonging to 
an ethical committee forces us to think globally and to decide case by case. In our 
monthly meeting, we have evolved continuously both in knowledge and in practice. 
Every project is a challenge for discussion, and every problem is an opportunity to 
think over about the way to improve ethical awareness, in an increasingly globalized 
and informed world, but somehow with less time to stop and think. As a result, 
more than 80% of projects were approved without ethical constraints.
However, many of the projects submitted for appreciation showed ethical 
constraints, reflecting the distance between research methods and ethical details:
1. Lack of informed consent. Some researchers think the informed consent is 
expendable. Others think that informed consent is just a signature in a paper 
sheet, overlooking the relevance of the information and the explanation to give 
participants the capacity of accepting consciously and freely [11].
2. The invitation to participate in the study. It’s hard for a patient assisted in a 
clinic to refuse the participation in a study when invited by his/her doctor or 
nurse. It is not forbidden, but this vulnerability forces researchers to be more 
cautious in the way they include their patients in the study, for example, by 
asking another member of the team to talk with the patient. This is particularly 
relevant in the primary care due to the proximity of doctor-patient relationship.
3. Data collection. Clinical files keep a lot of health data of interest for research. 
However, these data are available for healthcare and not so much for investiga-
tion. The reuse of data implies a legitimacy that does not derive directly from 
assistance. The free informed consent of the patient or his/her agent is the right 
way to do it. Nevertheless, under certain circumstances, ethical committee 
may excuse the explicit consent, but special care must be taken to minimize, 
anonymize, and secure data.
4. Variables under study. It’s common to see data collection forms including 
identification variables such as the patient’s name, birth date, or health system 
number. This potentially jeopardizes the anonymization and confidentiality 
of the database. Rarely these variables are relevant for research and should be 
avoided or duly justified [11].
5. Use of questionnaires of other authors. Many questionnaires are protected 
by copyright and must be authorized by their owners. Even if they are on the 
public domain, the questionnaire has an intellectual property that should be re-
spected. It’s appropriate to obtain prior authorization from the original authors.
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6. Absence of a well-defined statistical analytical plan. Quantitative studies may 
have an exploratory approach to data with all the limitations that poses for caus-
al inference. Still, an exploratory approach may be helpful for theory genera-
tion. For the purpose of theory testing, prespecification of statistical analysis is 
warranted. Researchers should identify all variables in the study and specify the 
statistical modeling and testing that will be used. This is an important procedure 
to mitigate “p-hacking” practices [12].
7. Lack of feedback to the participants. Researchers should commit with the 
obligation of informing participants if they identify a health or social problem 
that needs intervention, during the investigations. Whenever it is appropri-
ate, a definition of adverse event and a procedure for reporting and managing 
adverse events is expected.
8. Declaration of conflicts of interest. Although there’s a general acceptance 
about the definition of conflicts of interest in its several dimensions of finan-
cial ties, academic commitments, personal relationships, political or religious 
beliefs, and institutional affiliations, many times researchers opt by an indi-
vidual assessment choosing which characteristics are more prone to set up a 
conflict in the particular case. Everyone has some kind of conflicts of interest 
[13]. The transparency and truth is also an ethical duty.
5. Weaknesses of ethical review
Current trend of ethical review seems likely to make ethical approval less 
efficient and less sustainable both in terms of time and money [12]. We can identify 
potential types of weakness in different places and in different areas of the pathway 
of ethical review.
Ethics is not an exact science, including several lines of thought, from 
Aristotelian virtue to Kantian deontology, the deterministic theories, the situational 
view, the Buberian relational perspective, and many others. Different decisions may 
arise from different points of view [7].
The most frequent hazards in clinical investigation are the breach of confiden-
tiality, the adequacy of informed consent, and the protection of personal data. 
Patients are often the weakest link in the research project, unable to control most 
of the procedures in the protocol. But they may be also the strongest piece as they 
have the power to drop off, conditioning a potential bias able to weaken the inter-
pretation of the outcomes. It’s crucial to implement good strategies to safeguard 
voluntary informed consent, allowing the responsible freedom of the participants, 
based on effective information, especially when researchers are involved in their 
healthcare assistance [14].
Nowadays, many researchers use a standardized form to submit their study 
proposals to research ethics committees. The form overcomes the problem of 
inconsistencies in the paperwork required by different committees or, sometimes, by 
different members of the same committee. However, this procedure is time-consum-
ing, and many times a work overloads, forcing the researchers to adapt their study 
protocol to a closed predefined form. Instead of the original idea of simplifying the 
process, there’s a real risk of increasing the paperwork.
The informed consent is the key to legitimate the inclusion of the participants. 
However, its necessity may introduce some bias in the research. In primary care, 
socio-epidemiologic studies are common, and surveys frequently used methodolog-
ical strategies. The requirement for a written consent will overload the paperwork 
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and may withdraw some participants, leading to lower response rates and condi-
tioning the results [15].
One of the most important fundamental and central aspects of ethical review is 
the essential information necessary for ethical approval. That information can be 
written in form of questions [15]:
• Can the research protocol be modified to reduce potential hazards, without 
compromising its ability to answer the research question?
• Can the protocol study include solutions to minimize the chances that the 
remaining hazards result in harms?
• Are the hazards or the risk of resulting in harm disproportionately great in 
comparison to the importance of the new knowledge to be gained?
Another weakness commonly appointed to the ethical committees is the lack of 
expertise in specific scientific domains or in certain methodological approaches. 
The deliberations of research ethics committees require knowledge not only of 
ethical principles but also of different study designs and research topics. It is true 
that single members of research ethics committees usually do not have expertise in 
all of these domains for a given application. The way to prevent this weakness is to 
increase the number and the interdisciplinarity of the members of each research 
ethical committee. Portuguese health minister made recently an actualization of 
the regulation of health and research ethical committees, increasing the number of 
members to a maximum of 11 and imposing the obligation to integrate people from 
different areas such as medicine, justice, philosophy/ethics, theology, nursing and 
pharmacy, or even others as necessary. [16]
There are also some concerns about the time to answer. One reason is the 
bureaucratic issues inherent to its internal functioning, not always well understood, 
many times perfectly expendable, but always present in our experience. The main 
reason, however, is more relevant. Some projects raise doubts that require further 
reflection and imply to postpone the decision, giving time to mature each one’s 
opinions, based on each knowledge, sensitivities, experiences, and values, extended 
by self-education and, if needed, by consulting other experts.
There is a tendency to normalize the vision of the human being and his nature, 
leading to preconceived technical decisions, type “ready to wear.” This is more com-
mon as the time goes by and the routine settles in. The decision must be always case 
by case. Each project requires specific consideration, which extends over time in the 
implementation process.
The most important factor for weakness in ethical committees, as in many 
other organizations, is the inability to recognize their own limitations. This blind-
ness results in the lack of self-criticism and the affirmation that the decision is so 
perfect that everyone should accept without reservation. The solution is to maintain 
a deliberative environment in the ethical committees, with open dialog and real 
discussion on the different points of view, and the capacity to create consensus 
more that resorting to the decision by imposed suffrage.
6. Conclusion
Scientific inquiry and the production of new knowledge are central factors in the 
development of medicine and in improving the quality and quantity of life. It allows 
the generation of evidence about technologies and procedures offering information 
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useful for health reasoning and decision, whether with and for patients as individu-
als either for the population.
Thus, the emergence of a research question that does not yet have an established 
answer (often in the context of the clinical evaluation on medical consultation) is 
an opportunity to create new knowledge with the potential to improve the current 
situation.
Methodological strategies for hypothesis testing and for attainment of answers 
driven by research questions are known. Such procedures are expected to be suf-
ficiently described and structured in the investigation protocol.
Good practices require the submission of a protocol to an ethical committee 
prior to the start of participants’ inclusion.
Ethical committees are sometimes seen as an obstacle to the work of researchers. 
The most common criticisms arise from the difficulty in perceiving some scientific 
concepts due to a lack of training in that specific topic and a tendency to overvalue 
prejudices that lead to a certain paternalistic attitude towards patients and distrust 
towards researchers. The historically established police character of ethical commit-
tees also contributes to this depreciation.
On the other hand, researchers have a tendency to facilitate processes based on 
their perception of excellence of the expected results and to forget (or even not 
know) current regulations and laws.
Ethical committees are a fundamental instrument of self-regulation that seek a 
balance between the benefit of research and its results (that may be translated into 
more and better health) and the respect for the participant has a human being in his 
biopsychosocial dimensions.
In its Greek genesis, ethics derives from ēthikós, which means relating to one’s 
character. Thus, ethics refers to the ability to live with you and with others respect-
ing individual freedom and its limits by realizing that any act on our part will have a 
significant influence on the other and therefore must always be weighed.
This may be the key to solve the apparent dilemma. Introducing this consid-
eration in the design and implementation of the research turns it into an ethical 
investigation that we all agree on.
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